IVOSIDENIB
Manner of administration:Oral
Restriction (Streamlined authority code: 16701)
Indication: Locally advanced or metastatic cholangiocarcinoma
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 5 | DPMQ: $20,082.93 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tibsovo | |||||